Commit Biologics ApS: Financial statements 2025
CVR: 42642649
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Commit Biologics ApS (CVR 42642649) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -23,365,247 and a net result of DKK -33,781,079 compared with DKK -39,360,775 the year before. Equity in the 2025 report amounted to DKK 37,898,027. The solvency ratio was 97.7%. The company had 17 employees in the financial year.
- Gross Profit
- DKK -23,365,247
- Profit/Loss
- DKK -33,781,079
- Equity
- DKK 37,898,027
- Total Assets
- DKK 38,807,917
- Employees
- 17
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -23.4 mio. | -33.8 mio. | 37.9 mio. | 17 |
| 2024 | - | -31.4 mio. | -39.4 mio. | 23.2 mio. | 13 |
| 2023 | - | -13.6 mio. | -17.3 mio. | 22.6 mio. | 10 |
How creditworthy is Commit Biologics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of July 10, 2025, Mikkel Wandahl Pedersen has joined the board of directors of Commit Biologics ApS.
Commit Biologics ApS has published its annual report for 2024. Gross profit came to DKK -31,408,009, and the net result was DKK -39,360,775.
As of January 11, 2025, Krishna Reddy Polu has left the board of directors of Commit Biologics ApS.
As of January 11, 2025, Mikkel Wandahl Pedersen is registered as adm. dir. of Commit Biologics ApS.
As of January 11, 2025, Krishna Reddy Polu has stepped down as adm. dir. of Commit Biologics ApS.
About Commit Biologics ApS
Commit Biologics ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Thomas Lars Andresen. The company's owners include Novo Holdings A/S, Commit Biologics Holding ApS and Bioqube Factory Fund I CommV. In 2025, the company reported a gross profit of DKK -23,365,247 and a net result of DKK -33,781,079 compared with DKK -39,360,775 the year before. Equity in the 2025 report amounted to DKK 37,898,027.